Ahmed Mahiuddin 4
4 · Y-mAbs Therapeutics, Inc. · Filed May 20, 2020
Insider Transaction Report
Form 4
Ahmed Mahiuddin
Sr. VP & Chief Scientific Off
Transactions
- Sale
Common Stock
2020-05-19$39.24/sh−10,000$392,403→ 200,000 total - Sale
Common Stock
2020-05-18$39.49/sh−19,492$769,675→ 210,000 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $ 39.000 to $ 40.3000. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $ 38.6300 to $ 39.5750. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.